Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Deferred Revenue (2020 - 2025)

NeuroPace (NPCE) has 4 years of Current Deferred Revenue data on record, last reported at $141000.0 in Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 74.59% year-over-year to $141000.0; the TTM value through Dec 2025 reached $141000.0, down 74.59%, while the annual FY2025 figure was $141000.0, 74.59% down from the prior year.
  • Current Deferred Revenue reached $141000.0 in Q4 2025 per NPCE's latest filing, down from $600000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.1 million in Q4 2023 and bottomed at $141000.0 in Q4 2025.
  • Average Current Deferred Revenue over 3 years is $690555.6, with a median of $700000.0 recorded in 2025.
  • The widest YoY moves for Current Deferred Revenue: up 12.5% in 2025, down 74.59% in 2025.
  • A 3-year view of Current Deferred Revenue shows it stood at $1.1 million in 2023, then tumbled by 49.08% to $555000.0 in 2024, then plummeted by 74.59% to $141000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $141000.0 in Q4 2025, $600000.0 in Q3 2025, and $700000.0 in Q2 2025.